Scientific Programme

Preliminary (as per 25/10/2023)

Thursday, March 14th, 2024
10:00 – 19:00 REG Working Group Meetings
Friday, March 15th, 2024
08:50 – 09:00 Welcome
09:00 – 09:55 Vaccines session
  • Epidemiologic perspective of vaccination in respiratory diseases
  • Vaccinations & the respiratory patient –  Recommendations vs real world use
09:55 – 10:30 ILD/IPF Session
  • TBA
  • Q & A
10:30 – 11:00 Coffee Break
11:00 – 12:30 Asthma Session
  • Mild asthma, update on anti-inflammatory reliever
  • When to institute triple therapy – Should all patients go through triple therapy and azithromycin before biologics?
12:30 – 13:30 Lunch Break
13:30 – 14:15 COPD Session
  • The new natural history and aetiologies of COPD
  • What's next after triple therapy in COPD?
  • Q & A
14:15 – 15:00 Rhinitis session
  • Novel therapies in rhinitis
  • Rhinitis & asthma – what does the RWE tell us?
  • AIT & Biologics: a new opportunity of combination treatment
  • Q & A
15:00 – 15:30 Coffee Break

In the Respiratory hot seat:
15:30 – 16:15 PRO/CON Remission in severe asthma is attainable in most patients
16:15 – 17:00 PRO/CON Inhaled therapy in COPD: Once daily is the preferred option
17:00 – 17:45 PRO/CON DPIs are the devices of choice in COPD or asthma
Saturday, March 16th, 2024
09:00 – 09:45 Cough session
Specific cough-targeting drugs: past, present, and future
Q & A
09:45 – 10:30 Mild – Moderate disease management session
  • Identifying which patients progress to severe asthma – new evidence from MANI registry
  • Disease modifying drugs in asthma
10:30 – 11:00 Coffee Break
11:00 – 12:15 Severe asthma – Update from ISAR  
12:15 – 13:00 Keynote
What Registries have taught us in the last decade.  
13:00 Meeting Close